Wen PY - Search Results

1

Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas.

Shah GD, Kesari S, Xu R, Batchelor TT, O'Neill AM, Hochberg FH, Levy B, Bradshaw J, Wen PY. Shah GD, et al. Among authors: wen py. Neuro Oncol. 2006 Jan;8(1):38-46. doi: 10.1215/S1522851705000529. Neuro Oncol. 2006. PMID: 16443946 Free PMC article.

2

Radiosurgery as part of the initial management of patients with malignant gliomas.

Loeffler JS, Alexander E 3rd, Shea WM, Wen PY, Fine HA, Kooy HM, Black PM. Loeffler JS, et al. Among authors: wen py. J Clin Oncol. 1992 Sep;10(9):1379-85. doi: 10.1200/JCO.1992.10.9.1379. J Clin Oncol. 1992. PMID: 1325539

3

Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas.

Loeffler JS, Alexander E 3rd, Hochberg FH, Wen PY, Morris JH, Schoene WC, Siddon RL, Morse RH, Black PM. Loeffler JS, et al. Among authors: wen py. Int J Radiat Oncol Biol Phys. 1990 Dec;19(6):1455-62. doi: 10.1016/0360-3016(90)90358-q. Int J Radiat Oncol Biol Phys. 1990. PMID: 2262370 Clinical Trial.

4

Neurologic emergencies in cancer patients.

Schiff D, Batchelor T, Wen PY. Schiff D, et al. Among authors: wen py. Neurol Clin. 1998 May;16(2):449-83. doi: 10.1016/s0733-8619(05)70072-4. Neurol Clin. 1998. PMID: 9537970 Review.

5

A phase I trial of a new recombinant human beta-interferon (BG9015) for the treatment of patients with recurrent gliomas.

Fine HA, Wen PY, Robertson M, O'Neill A, Kowal J, Loeffler JS, Black PM. Fine HA, et al. Among authors: wen py. Clin Cancer Res. 1997 Mar;3(3):381-7. Clin Cancer Res. 1997. PMID: 9815695 Clinical Trial.

6

Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas.

Fine HA, Figg WD, Jaeckle K, Wen PY, Kyritsis AP, Loeffler JS, Levin VA, Black PM, Kaplan R, Pluda JM, Yung WK. Fine HA, et al. Among authors: wen py. J Clin Oncol. 2000 Feb;18(4):708-15. doi: 10.1200/JCO.2000.18.4.708. J Clin Oncol. 2000. PMID: 10673511 Clinical Trial.

7

Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.

Fine HA, Wen PY, Maher EA, Viscosi E, Batchelor T, Lakhani N, Figg WD, Purow BW, Borkowf CB. Fine HA, et al. Among authors: wen py. J Clin Oncol. 2003 Jun 15;21(12):2299-304. doi: 10.1200/JCO.2003.08.045. J Clin Oncol. 2003. PMID: 12805330 Clinical Trial.

8

Malignant gliomas.

Wen PY, Kesari S. Wen PY, et al. Curr Neurol Neurosci Rep. 2004 May;4(3):218-27. doi: 10.1007/s11910-004-0042-4. Curr Neurol Neurosci Rep. 2004. PMID: 15102348 Review.

9

Therapy for recurrent malignant glioma in adults.

Mrugala MM, Kesari S, Ramakrishna N, Wen PY. Mrugala MM, et al. Among authors: wen py. Expert Rev Anticancer Ther. 2004 Oct;4(5):759-82. doi: 10.1586/14737140.4.5.759. Expert Rev Anticancer Ther. 2004. PMID: 15485312 Review.

10

Targeted molecular therapy of malignant gliomas.

Kesari S, Ramakrishna N, Sauvageot C, Stiles CD, Wen PY. Kesari S, et al. Among authors: wen py. Curr Neurol Neurosci Rep. 2005 May;5(3):186-97. doi: 10.1007/s11910-005-0046-8. Curr Neurol Neurosci Rep. 2005. PMID: 15865884 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

633 results

Search Page